These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38089634)

  • 1. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes.
    Kuang M; Qiu J; Li D; Hu C; Zhang S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1281524. PubMed ID: 38089634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.
    Yang R; Kuang M; Qiu J; Yu C; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1172323. PubMed ID: 37538796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    Elguezabal Rodelo RG; Porchia LM; Torres-Rasgado E; López-Bayghen E; Gonzalez-Mejia ME
    PLoS One; 2024; 19(2):e0298662. PubMed ID: 38394065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.
    Feng Y; Yang X; Li Y; Wu Y; Han M; Qie R; Huang S; Wu X; Zhang Y; Liu D; Hu F; Zhang M; Yang Y; Shi X; Lu J; Zhao Y; Hu D
    Nutrition; 2022 Jan; 93():111443. PubMed ID: 34563934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating a novel surrogate indicator of adipose accumulation in relation to erectile dysfunction.
    Deng CY; Ke XP; Guo XG
    Lipids Health Dis; 2024 May; 23(1):139. PubMed ID: 38741154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Hernández-Conde M; Llop E; Carrillo CF; Tormo B; Abad J; Rodriguez L; Perelló C; Gomez ML; Martínez-Porras JL; Puga NF; Trapero-Marugan M; Fraga E; Aracil CF; Panero JLC
    World J Gastroenterol; 2020 Nov; 26(42):6658-6668. PubMed ID: 33268953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Viveros-Ruiz TL; Almeda-Valdes P; Gomez-Velasco D; Mehta R; Elias-López D; Cruz-Bautista I; Roldán-Valadez E; Martagón AJ; Aguilar-Salinas CA
    Clin Nutr; 2020 May; 39(5):1613-1621. PubMed ID: 31400997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study.
    Yu P; Meng X; Kan R; Wang Z; Yu X
    Front Endocrinol (Lausanne); 2022; 13():1052736. PubMed ID: 36545336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between visceral fat metabolism score and erectile dysfunction: a cross-sectional study from NHANES 2001-2004.
    Huang L; Liu H; Li L; Wang S; Sun G
    Front Endocrinol (Lausanne); 2023; 14():1283545. PubMed ID: 38125791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the visceral fat metabolic score with osteoarthritis risk: a cross-sectional study from NHANES 2009-2018.
    Xue H; Zhang L; Xu J; Gao K; Zhang C; Jiang L; Lv S; Zhang C
    BMC Public Health; 2024 Aug; 24(1):2269. PubMed ID: 39169311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Yu SJ; Kim W; Kim D; Yoon JH; Lee K; Kim JH; Cho EJ; Lee JH; Kim HY; Kim YJ; Kim CY
    Medicine (Baltimore); 2015 Dec; 94(48):e2159. PubMed ID: 26632897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
    Cai X; Gao J; Hu J; Wen W; Zhu Q; Wang M; Liu S; Hong J; Wu T; Yang S; Tuerxun G; Li N
    Dis Markers; 2022; 2022():4930355. PubMed ID: 35251371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
    Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
    Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Score for Visceral Fat: a novel predictor for the risk of type 2 diabetes mellitus.
    Feng Y; Yang X; Li Y; Wu Y; Han M; Qie R; Huang S; Wu X; Zhang Y; Zhang J; Hu H; Yuan L; Li T; Liu D; Hu F; Zhang M; Zeng Y; Luo X; Lu J; Sun L; Hu D; Zhao Y
    Br J Nutr; 2022 Sep; 128(6):1029-1036. PubMed ID: 34632975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.
    Qiu J; Kuang M; He S; Yu C; Wang C; Huang X; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1302322. PubMed ID: 38125795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between metabolic score of visceral fat and carotid atherosclerosis in Chinese health screening population: a cross-sectional study.
    Qian J; Huang G; Mao Y
    BMC Public Health; 2024 Jun; 24(1):1723. PubMed ID: 38943105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.